Your browser doesn't support javascript.
Estimating severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence from residual clinical blood samples, January-March 2021.
Graciaa, Daniel S; Verkerke, Hans P; Guarner, Jeannette; Moldoveanu, Ana Maria; Cheedarla, Narayanaiah; Arthur, Connie M; Maier, Cheryl L; Neish, Andrew; Auld, Sara C; Campbell, Angie; Gandhi, Neel R; Roback, John D; Shah, N Sarita.
  • Graciaa DS; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
  • Verkerke HP; Department of Pathology & Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia.
  • Guarner J; Department of Pathology & Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia.
  • Moldoveanu AM; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
  • Cheedarla N; Department of Pathology & Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia.
  • Arthur CM; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Maier CL; Department of Pathology & Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia.
  • Neish A; Department of Pathology & Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia.
  • Auld SC; Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
  • Campbell A; Departments of Epidemiology and Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia.
  • Gandhi NR; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
  • Roback JD; Departments of Epidemiology and Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia.
  • Shah NS; Department of Pathology & Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia.
Antimicrob Steward Healthc Epidemiol ; 2(1): e159, 2022.
Article in English | MEDLINE | ID: covidwho-2086913
ABSTRACT
We describe severe acute respiratory coronavirus virus 2 (SARS-CoV-2) IgG seroprevalence and antigenemia among patients at a medical center in January-March 2021 using residual clinical blood samples. The overall seroprevalences were 17% by infection and 16% by vaccination. Spent or residual samples are a feasible alternative for rapidly estimating seroprevalence or monitoring trends in infection and vaccination.
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study Topics: Vaccines Language: English Journal: Antimicrob Steward Healthc Epidemiol Year: 2022 Document Type: Article Affiliation country: Ash.2022.298

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study Topics: Vaccines Language: English Journal: Antimicrob Steward Healthc Epidemiol Year: 2022 Document Type: Article Affiliation country: Ash.2022.298